VIRBAC overview

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577 Date Total number of shares representing the share capital Total number of voting rights October, 31 2024 8 390 660 Gross total of voting rights : 12 707 824...

KEY FIGURES Revenue at the end of September €1 042.1M Growth at constant exchange rates and scope 1 +8.6% including companion animals +11.9% farm animals +3.2% Growth at constant exchange rates 2 +14.0% Overall change +12.6% 1 growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of identi cal exchange...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577 Date Total number of shares representing the share capital Total number of voting rights September, 30 2024 8 390 660 Gross total of voting rights : 12 708...

This press release rectifies the version of the press release issued by Virbac on September 13, 2024 at 5:45 pm in order to correct a typing error in the amount of Virbac's new share capital. The share capital of Virbac amounts now to €10,488,325 and not €10,448,325 as announced. Focusing on animal health, from the beginning At Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our...

Public release of the Half-Year Financial Report at 30 June 2024. The Group released and filed its 2024 half-year financial report with the French “Autorité des marchés financiers”. The document is also available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”. Attachment Public release of the Half-Year Financial Report_06.24...

During the meeting held on September 13, 2024, the board of directors, acting on the authorization granted by the combined shareholders’ meeting on June 20, 2023, decided to reduce the share capital of Virbac by canceling 67,340 treasury shares. These shares were acquired during 2023 under the share buyback program authorized by the same shareholders’ meeting. As of today, the share capital of Virbac amounts to €10,448,325, represented by 8,390,660 shares of €1.25, fully paid-up....

Exceptional business momentum in the first half, with revenue up 16.1% at constant exchange rates Strong growth in adjusted current operating income 1 +3.4 points compared with 2023 to reach a record level at 21.4% of revenue 2024 targets confirmed Revenue growth expected between 7% and 9% at constant exchange rates and scope Adjusted current operating income 1 expected to be around 16% compared with 15.1% in 2023 CONSOLIDATED FIGURES AS AT JUNE 30 in € million 2024 2023 2024/2023 change...

At its meeting on September 13, 2024, the board of directors acknowledged the resignation of Sébastien Huron, effective as of September 27, 2024, from his positions as chief executive officer of Virbac and director of Virbac Limited (UK). On the recommendation of the appointments and compensation committee, the board of directors has decided on the financial terms of Sébastien Huron's departure, as set out below. Fixed compensation for 2024 In accordance with the compensation policy approved...